Cargando…

Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk

Bladder cancer is the fifth most common cancer in the United States, and identifying genetic markers that may predict susceptibility in high-risk population is always needed. The purpose of our study is to determine whether genetic variations in the transforming growth factor-beta (TGF-β) pathway ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Hua, Kamat, Ashish M., Aldousari, Saad, Ye, Yuanqing, Huang, Maosheng, Dinney, Colin P., Wu, Xifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520916/ https://www.ncbi.nlm.nih.gov/pubmed/23251617 http://dx.doi.org/10.1371/journal.pone.0051758

Ejemplares similares

Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette–Guérin
por: Williams, Stephen B., et al.
Publicado: (2017)

Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer
por: Lian, Jie, et al.
Publicado: (2018)

Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk
por: Chang, Joshua, et al.
Publicado: (2012)

Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development
por: Chen, Meng, et al.
Publicado: (2016)

Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guérin
por: Wei, Hua, et al.
Publicado: (2012)

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Li, Roger, et al.
Publicado: (2017)

Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer
por: Lin, Moubin, et al.
Publicado: (2017)

Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk
por: Wang, J, et al.
Publicado: (2013)

Plasmacytoid urothelial carcinoma of the bladder: a case report
por: Aldousari, Saad, et al.
Publicado: (2009)

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
por: Kamat, Ashish M., et al.
Publicado: (2017)

Cancer risk associated with chronic diseases and disease markers: prospective cohort study
por: Tu, Huakang, et al.
Publicado: (2018)

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.
por: Eder, I. E., et al.
Publicado: (1997)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
por: Oshiro, Hisashi, et al.
Publicado: (2016)

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells
por: TAKEUCHI, HISASHI, et al.
Publicado: (2015)

Bladder cancer: 2017 and beyond
por: Kamat, Ashish M.
Publicado: (2017)

Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
por: Jayaratna, Isuru S., et al.
Publicado: (2015)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types
por: Tu, Huakang, et al.
Publicado: (2022)

Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease
por: Kamat, Ashish M.
Publicado: (2021)

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval
por: Martini, Alberto, et al.
Publicado: (2023)

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study
por: Wang, Qinchuan, et al.
Publicado: (2020)

A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013)

Advances in risk stratification of bladder cancer to guide personalized medicine
por: Matulay, Justin T., et al.
Publicado: (2018)

Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013)

Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate
por: Kokorovic, Andrea, et al.
Publicado: (2021)

The Prognostic Value of Previous Irradiation on Survival of Bladder Cancer Patients
por: Krughoff, Kevin, et al.
Publicado: (2015)

Transforming Growth Factor Beta Leucine10 Proline Variation and Breast Cancer Risk in Iranian Women
por: DEHGHAN TEZERJANI, Masoud, et al.
Publicado: (2015)

Bladder exstrophy in adulthood
por: Nerli, R. B., et al.
Publicado: (2008)

Reduced Interleukin-17 and Transforming Growth Factor Beta Levels in Peripheral Blood as Indicators for Following the Course of Bladder Cancer
por: Baharlou, Rasoul, et al.
Publicado: (2014)

Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer
por: Zhou, Junhan, et al.
Publicado: (2020)

Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta
por: Baugé, Catherine, et al.
Publicado: (2011)

Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer
por: Agarwal, Piyus K., et al.
Publicado: (2008)

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
por: Jinesh G., Goodwin, et al.
Publicado: (2012)

A mathematical method to estimate angle and distance for percutaneous renal puncture based on computed tomography data: Description and validation
por: Salem, Shady Mohamed, et al.
Publicado: (2023)

Transforming growth factor-beta: possible roles in carcinogenesis.
por: Roberts, A. B., et al.
Publicado: (1988)

Transforming growth factor beta isoforms in breast cancer.
por: Benson, J. R., et al.
Publicado: (1994)

Transforming growth factor beta: the good, the bad, and the ugly
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_3mcdgrq93vcg78upsn46vbnk8r